Evidence map›Paper›PMID 24759720›Full record

ArticleJournal of clinical microbiology2014

Validation of a microbead-based format for spoligotyping of Legionella pneumophila.

Michel Kiréopori Gomgnimbou, Christophe Ginevra, Caroline Peron-Cane, Margaux Versapuech, Guislaine Refrégier, Nathalie Jacotin, Christophe Sola, Sophie Jarraud

Abstract readValidation Study
In one paragraph

Article in Journal of clinical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michel Kiréopori GomgnimbouInstitut de Génétique et Microbiologie, UMR8621, CNRS-Université Paris-Sud, Paris, France Centre Muraz, Bobo-Dioulasso, Burkina Faso.
Christophe GinevraCIRI, International Center for Infectiology Research, Legionella Pathogenesis Team, Université de Lyon, Lyon, France INSERM, U1111, Lyon, France Ecole Normale Supérieure de Lyon, Lyon, France Université Lyon 1, Centre International de Recherche en Infectiologie, Lyon, France CNRS, UMR5308, Lyon, France Centre National de Référence des légionelles, Centre de Biologie Est, Hospices Civils de Lyon, Lyon, France.
Caroline Peron-CaneInstitut de Génétique et Microbiologie, UMR8621, CNRS-Université Paris-Sud, Paris, France.
Margaux VersapuechInstitut de Génétique et Microbiologie, UMR8621, CNRS-Université Paris-Sud, Paris, France.
Guislaine RefrégierInstitut de Génétique et Microbiologie, UMR8621, CNRS-Université Paris-Sud, Paris, France.
Nathalie JacotinCIRI, International Center for Infectiology Research, Legionella Pathogenesis Team, Université de Lyon, Lyon, France INSERM, U1111, Lyon, France Ecole Normale Supérieure de Lyon, Lyon, France Université Lyon 1, Centre International de Recherche en Infectiologie, Lyon, France CNRS, UMR5308, Lyon, France Centre National de Référence des légionelles, Centre de Biologie Est, Hospices Civils de Lyon, Lyon, France.
Christophe SolaInstitut de Génétique et Microbiologie, UMR8621, CNRS-Université Paris-Sud, Paris, France christophe.sola@u-psud.fr.
Sophie JarraudCIRI, International Center for Infectiology Research, Legionella Pathogenesis Team, Université de Lyon, Lyon, France INSERM, U1111, Lyon, France Ecole Normale Supérieure de Lyon, Lyon, France Université Lyon 1, Centre International de Recherche en Infectiologie, Lyon, France CNRS, UMR5308, Lyon, France Centre National de Référence des légionelles, Centre de Biologie Est, Hospices Civils de Lyon, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 42-plex clustered regularly interspaced short palindromic repeat (CRISPR)-based typing technique (spoligotyping) was recently developed at the French National Reference Center for Legionella. It allows the subtyping of the Legionella pneumophila sequence type 1/Paris pulsotype. In this report, we present the transfer of the membrane-based spoligotyping technique to a microbead-based multiplexed format. This microbead-based high-throughput assay uses devices such as Luminex 200 or the recently launched Magpix system (Luminex Corp., Austin, TX). We designated this new technique LP-SPOL (for L. pneumophila spoligotyping). We used two sets of samples previously subtyped by the membrane-based spoligotyping method to set up and validate the transfer on the two microbead-based systems. The first set of isolates (n = 56) represented the whole diversity of the CRISPR patterns known to date. These isolates were used for transfer setup (determination of spacer cutoffs for both devices). The second set of isolates (n = 245) was used to validate the transfer to the two microbead-based systems. The results obtained by the Luminex 200 system were 100% concordant with those obtained by the Magpix system for the 2 sets of isolates. In total, 10 discrepant results were observed when comparing the membrane-based method to the microbead-based method. These discrepancies were further resolved by repeating either the membrane-based or the microbead-based assay. This new assay is expected to play an emerging role for surveillance of L. pneumophila, starting with one of the most frequent genotypes, the sequence type 1/Paris pulsotype. However, the generalization of this typing method to all L. pneumophila strains is not feasible, since not all L. pneumophila strains contain CRISPRs.

Indexed as

MicrospheresAutomation, LaboratoryFranceHigh-Throughput Screening AssaysHumansLegionella pneumophilaMolecular EpidemiologyMolecular Typing

Identifiers

PMID24759720
PMCPMC4097685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.